Global Oral Contrast Agent Market Research Report 2023

Report ID: 1970199 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Oral Contrast Agent Market Overview
    1.1 Product Overview and Scope of Oral Contrast Agent
    1.2 Oral Contrast Agent Segment by Type
        1.2.1 Global Oral Contrast Agent Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Barium-based Contrast Media
        1.2.3 Iodinated Contrast Media
        1.2.4 Gadolinium-based Contrast Media
        1.2.5 Microbubble Contrast Media
    1.3 Oral Contrast Agent Segment by Application
        1.3.1 Global Oral Contrast Agent Sales Comparison by Application: (2022-2028)
        1.3.2 Cardiovascular Disorders
        1.3.3 Cancer
        1.3.4 Gastrointestinal Disorders
        1.3.5 Musculoskeletal Disorders
        1.3.6 Neurological Disorders
        1.3.7 Nephrological Disorders
    1.4 Global Oral Contrast Agent Market Size Estimates and Forecasts
        1.4.1 Global Oral Contrast Agent Revenue 2017-2028
        1.4.2 Global Oral Contrast Agent Sales 2017-2028
        1.4.3 Oral Contrast Agent Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Contrast Agent Market Competition by Manufacturers
    2.1 Global Oral Contrast Agent Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Oral Contrast Agent Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Oral Contrast Agent Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Oral Contrast Agent Manufacturing Sites, Area Served, Product Type
    2.5 Oral Contrast Agent Market Competitive Situation and Trends
        2.5.1 Oral Contrast Agent Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Oral Contrast Agent Players Market Share by Revenue
        2.5.3 Global Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Contrast Agent Retrospective Market Scenario by Region
    3.1 Global Oral Contrast Agent Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Oral Contrast Agent Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Oral Contrast Agent Market Facts & Figures by Country
        3.3.1 North America Oral Contrast Agent Sales by Country
        3.3.2 North America Oral Contrast Agent Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Oral Contrast Agent Market Facts & Figures by Country
        3.4.1 Europe Oral Contrast Agent Sales by Country
        3.4.2 Europe Oral Contrast Agent Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Oral Contrast Agent Market Facts & Figures by Region
        3.5.1 Asia Pacific Oral Contrast Agent Sales by Region
        3.5.2 Asia Pacific Oral Contrast Agent Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Oral Contrast Agent Market Facts & Figures by Country
        3.6.1 Latin America Oral Contrast Agent Sales by Country
        3.6.2 Latin America Oral Contrast Agent Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Country
        3.7.1 Middle East and Africa Oral Contrast Agent Sales by Country
        3.7.2 Middle East and Africa Oral Contrast Agent Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Oral Contrast Agent Historic Market Analysis by Type
    4.1 Global Oral Contrast Agent Sales Market Share by Type (2017-2022)
    4.2 Global Oral Contrast Agent Revenue Market Share by Type (2017-2022)
    4.3 Global Oral Contrast Agent Price by Type (2017-2022)
5 Global Oral Contrast Agent Historic Market Analysis by Application
    5.1 Global Oral Contrast Agent Sales Market Share by Application (2017-2022)
    5.2 Global Oral Contrast Agent Revenue Market Share by Application (2017-2022)
    5.3 Global Oral Contrast Agent Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 GE Healthcare (US)
        6.1.1 GE Healthcare (US) Corporation Information
        6.1.2 GE Healthcare (US) Description and Business Overview
        6.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
        6.1.5 GE Healthcare (US) Recent Developments/Updates
    6.2 Bracco Imaging (Italy)
        6.2.1 Bracco Imaging (Italy) Corporation Information
        6.2.2 Bracco Imaging (Italy) Description and Business Overview
        6.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
        6.2.5 Bracco Imaging (Italy) Recent Developments/Updates
    6.3 Bayer HealthCare (Germany)
        6.3.1 Bayer HealthCare (Germany) Corporation Information
        6.3.2 Bayer HealthCare (Germany) Description and Business Overview
        6.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
        6.3.5 Bayer HealthCare (Germany) Recent Developments/Updates
    6.4 Guerbet (France)
        6.4.1 Guerbet (France) Corporation Information
        6.4.2 Guerbet (France) Description and Business Overview
        6.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Guerbet (France) Oral Contrast Agent Product Portfolio
        6.4.5 Guerbet (France) Recent Developments/Updates
    6.5 Lantheus (US)
        6.5.1 Lantheus (US) Corporation Information
        6.5.2 Lantheus (US) Description and Business Overview
        6.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Lantheus (US) Oral Contrast Agent Product Portfolio
        6.5.5 Lantheus (US) Recent Developments/Updates
    6.6 Daiichi Sankyo (Japan)
        6.6.1 Daiichi Sankyo (Japan) Corporation Information
        6.6.2 Daiichi Sankyo (Japan) Description and Business Overview
        6.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
        6.6.5 Daiichi Sankyo (Japan) Recent Developments/Updates
    6.7 Unijules Life Sciences (India)
        6.6.1 Unijules Life Sciences (India) Corporation Information
        6.6.2 Unijules Life Sciences (India) Description and Business Overview
        6.6.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
        6.7.5 Unijules Life Sciences (India) Recent Developments/Updates
    6.8 J.B. Chemicals and Pharmaceuticals (India)
        6.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
        6.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
        6.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
        6.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments/Updates
    6.9 Spago Nanomedicine (Sweden)
        6.9.1 Spago Nanomedicine (Sweden) Corporation Information
        6.9.2 Spago Nanomedicine (Sweden) Description and Business Overview
        6.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
        6.9.5 Spago Nanomedicine (Sweden) Recent Developments/Updates
    6.10 Taejoon Pharm (South Korea)
        6.10.1 Taejoon Pharm (South Korea) Corporation Information
        6.10.2 Taejoon Pharm (South Korea) Description and Business Overview
        6.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
        6.10.5 Taejoon Pharm (South Korea) Recent Developments/Updates
    6.11 Jodas (India)
        6.11.1 Jodas (India) Corporation Information
        6.11.2 Jodas (India) Oral Contrast Agent Description and Business Overview
        6.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Jodas (India) Oral Contrast Agent Product Portfolio
        6.11.5 Jodas (India) Recent Developments/Updates
    6.12 Magnus Health (India)
        6.12.1 Magnus Health (India) Corporation Information
        6.12.2 Magnus Health (India) Oral Contrast Agent Description and Business Overview
        6.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
        6.12.5 Magnus Health (India) Recent Developments/Updates
7 Oral Contrast Agent Manufacturing Cost Analysis
    7.1 Oral Contrast Agent Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Oral Contrast Agent
    7.4 Oral Contrast Agent Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Oral Contrast Agent Distributors List
    8.3 Oral Contrast Agent Customers
9 Oral Contrast Agent Market Dynamics
    9.1 Oral Contrast Agent Industry Trends
    9.2 Oral Contrast Agent Market Drivers
    9.3 Oral Contrast Agent Market Challenges
    9.4 Oral Contrast Agent Market Restraints
10 Global Market Forecast
    10.1 Oral Contrast Agent Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Oral Contrast Agent by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Oral Contrast Agent by Type (2023-2028)
    10.2 Oral Contrast Agent Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Oral Contrast Agent by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Oral Contrast Agent by Application (2023-2028)
    10.3 Oral Contrast Agent Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Oral Contrast Agent by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Oral Contrast Agent by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Oral Contrast Agent Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Oral Contrast Agent Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Oral Contrast Agent Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Oral Contrast Agent Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Oral Contrast Agent Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Oral Contrast Agent Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Oral Contrast Agent Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Oral Contrast Agent Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Oral Contrast Agent Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Oral Contrast Agent Manufacturing Sites and Area Served
    Table 11. Manufacturers Oral Contrast Agent Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Oral Contrast Agent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Contrast Agent as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Oral Contrast Agent Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Oral Contrast Agent Sales Market Share by Region (2017-2022)
    Table 17. Global Oral Contrast Agent Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Oral Contrast Agent Revenue Market Share by Region (2017-2022)
    Table 19. North America Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Oral Contrast Agent Sales Market Share by Country (2017-2022)
    Table 21. North America Oral Contrast Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Oral Contrast Agent Revenue Market Share by Country (2017-2022)
    Table 23. Europe Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Oral Contrast Agent Sales Market Share by Country (2017-2022)
    Table 25. Europe Oral Contrast Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Oral Contrast Agent Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Oral Contrast Agent Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Oral Contrast Agent Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Oral Contrast Agent Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Oral Contrast Agent Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Oral Contrast Agent Sales Market Share by Country (2017-2022)
    Table 33. Latin America Oral Contrast Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Oral Contrast Agent Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Oral Contrast Agent Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Oral Contrast Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Oral Contrast Agent Revenue Market Share by Country (2017-2022)
    Table 39. Global Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Oral Contrast Agent Sales Market Share by Type (2017-2022)
    Table 41. Global Oral Contrast Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Oral Contrast Agent Revenue Share by Type (2017-2022)
    Table 43. Global Oral Contrast Agent Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Oral Contrast Agent Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Oral Contrast Agent Sales Market Share by Application (2017-2022)
    Table 46. Global Oral Contrast Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Oral Contrast Agent Revenue Share by Application (2017-2022)
    Table 48. Global Oral Contrast Agent Price by Application (2017-2022) & (USD/Pcs)
    Table 49. GE Healthcare (US) Corporation Information
    Table 50. GE Healthcare (US) Description and Business Overview
    Table 51. GE Healthcare (US) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. GE Healthcare (US) Oral Contrast Agent Product
    Table 53. GE Healthcare (US) Recent Developments/Updates
    Table 54. Bracco Imaging (Italy) Corporation Information
    Table 55. Bracco Imaging (Italy) Description and Business Overview
    Table 56. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Bracco Imaging (Italy) Oral Contrast Agent Product
    Table 58. Bracco Imaging (Italy) Recent Developments/Updates
    Table 59. Bayer HealthCare (Germany) Corporation Information
    Table 60. Bayer HealthCare (Germany) Description and Business Overview
    Table 61. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Bayer HealthCare (Germany) Oral Contrast Agent Product
    Table 63. Bayer HealthCare (Germany) Recent Developments/Updates
    Table 64. Guerbet (France) Corporation Information
    Table 65. Guerbet (France) Description and Business Overview
    Table 66. Guerbet (France) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Guerbet (France) Oral Contrast Agent Product
    Table 68. Guerbet (France) Recent Developments/Updates
    Table 69. Lantheus (US) Corporation Information
    Table 70. Lantheus (US) Description and Business Overview
    Table 71. Lantheus (US) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Lantheus (US) Oral Contrast Agent Product
    Table 73. Lantheus (US) Recent Developments/Updates
    Table 74. Daiichi Sankyo (Japan) Corporation Information
    Table 75. Daiichi Sankyo (Japan) Description and Business Overview
    Table 76. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Daiichi Sankyo (Japan) Oral Contrast Agent Product
    Table 78. Daiichi Sankyo (Japan) Recent Developments/Updates
    Table 79. Unijules Life Sciences (India) Corporation Information
    Table 80. Unijules Life Sciences (India) Description and Business Overview
    Table 81. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Unijules Life Sciences (India) Oral Contrast Agent Product
    Table 83. Unijules Life Sciences (India) Recent Developments/Updates
    Table 84. J.B. Chemicals and Pharmaceuticals (India) Corporation Information
    Table 85. J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
    Table 86. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product
    Table 88. J.B. Chemicals and Pharmaceuticals (India) Recent Developments/Updates
    Table 89. Spago Nanomedicine (Sweden) Corporation Information
    Table 90. Spago Nanomedicine (Sweden) Description and Business Overview
    Table 91. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Spago Nanomedicine (Sweden) Oral Contrast Agent Product
    Table 93. Spago Nanomedicine (Sweden) Recent Developments/Updates
    Table 94. Taejoon Pharm (South Korea) Corporation Information
    Table 95. Taejoon Pharm (South Korea) Description and Business Overview
    Table 96. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Taejoon Pharm (South Korea) Oral Contrast Agent Product
    Table 98. Taejoon Pharm (South Korea) Recent Developments/Updates
    Table 99. Jodas (India) Corporation Information
    Table 100. Jodas (India) Description and Business Overview
    Table 101. Jodas (India) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. Jodas (India) Oral Contrast Agent Product
    Table 103. Jodas (India) Recent Developments/Updates
    Table 104. Magnus Health (India) Corporation Information
    Table 105. Magnus Health (India) Description and Business Overview
    Table 106. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 107. Magnus Health (India) Oral Contrast Agent Product
    Table 108. Magnus Health (India) Recent Developments/Updates
    Table 109. Production Base and Market Concentration Rate of Raw Material
    Table 110. Key Suppliers of Raw Materials
    Table 111. Oral Contrast Agent Distributors List
    Table 112. Oral Contrast Agent Customers List
    Table 113. Oral Contrast Agent Market Trends
    Table 114. Oral Contrast Agent Market Drivers
    Table 115. Oral Contrast Agent Market Challenges
    Table 116. Oral Contrast Agent Market Restraints
    Table 117. Global Oral Contrast Agent Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 118. Global Oral Contrast Agent Sales Market Share Forecast by Type (2023-2028)
    Table 119. Global Oral Contrast Agent Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 120. Global Oral Contrast Agent Revenue Market Share Forecast by Type (2023-2028)
    Table 121. Global Oral Contrast Agent Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 122. Global Oral Contrast Agent Sales Market Share Forecast by Application (2023-2028)
    Table 123. Global Oral Contrast Agent Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 124. Global Oral Contrast Agent Revenue Market Share Forecast by Application (2023-2028)
    Table 125. Global Oral Contrast Agent Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 126. Global Oral Contrast Agent Sales Market Share Forecast by Region (2023-2028)
    Table 127. Global Oral Contrast Agent Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 128. Global Oral Contrast Agent Revenue Market Share Forecast by Region (2023-2028)
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Oral Contrast Agent
    Figure 2. Global Oral Contrast Agent Market Share by Type in 2021 & 2028
    Figure 3. Barium-based Contrast Media Product Picture
    Figure 4. Iodinated Contrast Media Product Picture
    Figure 5. Gadolinium-based Contrast Media Product Picture
    Figure 6. Microbubble Contrast Media Product Picture
    Figure 7. Global Oral Contrast Agent Market Share by Application in 2021 & 2028
    Figure 8. Cardiovascular Disorders
    Figure 9. Cancer
    Figure 10. Gastrointestinal Disorders
    Figure 11. Musculoskeletal Disorders
    Figure 12. Neurological Disorders
    Figure 13. Nephrological Disorders
    Figure 14. Global Oral Contrast Agent Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Oral Contrast Agent Market Size (2017-2028) & (US$ Million)
    Figure 16. Global Oral Contrast Agent Sales (2017-2028) & (K Pcs)
    Figure 17. Oral Contrast Agent Sales Share by Manufacturers in 2021
    Figure 18. Global Oral Contrast Agent Revenue Share by Manufacturers in 2021
    Figure 19. The Global 5 and 10 Largest Oral Contrast Agent Players: Market Share by Revenue in 2021
    Figure 20. Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Oral Contrast Agent Sales Market Share by Region (2017-2022)
    Figure 22. Global Oral Contrast Agent Sales Market Share by Region in 2021
    Figure 23. Global Oral Contrast Agent Revenue Market Share by Region (2017-2022)
    Figure 24. Global Oral Contrast Agent Revenue Market Share by Region in 2021
    Figure 25. U.S. Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Canada Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Germany Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. France Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. U.K. Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Italy Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Russia Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Japan Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. South Korea Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. India Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Australia Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Taiwan Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Indonesia Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Thailand Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Malaysia Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Philippines Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Vietnam Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Mexico Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Brazil Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Argentina Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Turkey Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Saudi Arabia Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. UAE Oral Contrast Agent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Sales Market Share of Oral Contrast Agent by Type (2017-2022)
    Figure 50. Manufacturing Cost Structure of Oral Contrast Agent
    Figure 51. Manufacturing Process Analysis of Oral Contrast Agent
    Figure 52. Oral Contrast Agent Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Frequently Asked Questions
Oral Contrast Agent report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Contrast Agent report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Contrast Agent report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Urology Instrument

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More